Major manufacturers of leucovorin include Hikma Pharmaceuticals, Fresenius Kabi, and Amneal Pharmaceuticals [1][2]. These companies produce the drug, which is used in various chemotherapy regimens to counteract the effects of certain cancer drugs, like methotrexate, and is also employed in treating colorectal cancer [3].
When do leucovorin patents expire?
The patent landscape for leucovorin is complex, as it is an older drug. While specific patent expiry dates can vary and are often linked to new formulations or delivery methods, the core patent protection for the original drug has likely expired. DrugPatentWatch.com offers resources to track patent information for pharmaceutical products [4].
What are the uses of leucovorin?
Leucovorin, also known as folinic acid, is primarily used as a rescue agent after high-dose methotrexate therapy to protect healthy cells from its toxic effects [3][5]. It is also used in combination with fluorouracil for the treatment of advanced colorectal cancer [3]. Additionally, it can be used to potentiate the effects of fluorouracil in certain cancers [5].
Can generic versions of leucovorin be manufactured?
Yes, generic versions of leucovorin are available on the market. The presence of multiple manufacturers like Hikma Pharmaceuticals, Fresenius Kabi, and Amneal Pharmaceuticals indicates that generic competition exists [1][2].
How does leucovorin work in cancer treatment?
Leucovorin works by providing a reduced form of folic acid that bypasses the metabolic step inhibited by methotrexate. Methotrexate works by inhibiting dihydrofolate reductase, an enzyme essential for DNA synthesis. Leucovorin supplements the folate pool, allowing normal cells to synthesize DNA and thus mitigating the toxicity of methotrexate. In colorectal cancer treatment, leucovorin is used in conjunction with fluorouracil (5-FU) to enhance the anticancer activity of 5-FU. Leucovorin stabilizes the binding of fluorouracil to thymidylate synthase, an enzyme crucial for DNA synthesis in cancer cells, thereby increasing cell death [3][5].
What are the potential side effects of leucovorin?
While generally well-tolerated, leucovorin can cause side effects. These may include allergic reactions, such as rash or hives, and gastrointestinal issues like nausea and vomiting [5]. In rare cases, it can cause seizures [3]. Patients are advised to report any adverse effects to their healthcare provider [5].
How is leucovorin administered?
Leucovorin is typically administered intravenously (IV) or orally [3][5]. The dosage and route of administration depend on the specific medical condition being treated and the concurrent therapies being used [5].
---
Sources:
[1] https://www.drugpatentwatch.com/drug/leucovorin
[2] https://www.drugpatentwatch.com/companies/amneal-pharmaceuticals
[3] https://www.drugpatentwatch.com/drug/leucovorin/uses
[4] https://www.drugpatentwatch.com/
[5] https://www.drugpatentwatch.com/drug/leucovorin/safety